Presentations

Pre-Session

• Carol Linden - The Integrated National Biodefense Medical Countermeasures (MCM) Portfolio Initiative

Session 1

• Debra Sharpe - CHALLENGES AND LESSONS LEARNED BRINGING DOWN AN ENHANCED ANIMAL BSL-3 FACILITY FOR ANNUAL MAINTENANCE AND VERIFICATION
• Jean(Fred) Khoshbin - The Impact of Facility on Science
• Martin Orlowski - Hydrogen Peroxide Bio-Decontamination
• Chad J. Roy - Infectious Disease Aerobiology
• Paul Anderson - Aerobiology at the University of Missouri: Regional Biocontainment Laboratory

Session 2

• Freyja Lynn - Concepts and Considerations for Assay Development, Qualification, Validation and Routine Use
• Melissa S. Willis - The Importance of Standardized Reagents for Animal Challenge Studies
• Susan K. McCune - The 'Animal Rule' and Essential Elements of Animal Models

Session 3

• Anne-Sophie Brocard - Why should you develop a training program at your institution?
• Carol D. Linden - Strengthening the Biosecurity of the United States
• Debra L. Hunt - The National Biosafety and Biocontainment Training Program: "Culturing a New Generation of Biosafety Professionals"
• Kimberly Orr - Review of Commerce Controls on Biological Agents and Equipment
• Debra Sharpe - New Challenges in Biosecurity and Biosurety: How to Take a Rational Approach to Ensure Compliance

Session 4

• Trevor Brasel - Modeling Lung Deposition of Bioaerosols in Monkeys
• Gene E. McClellan - An Improved Model of Human Response to Aerosol Chemical and Biological Agent Hazards

Session 5

• Steven Storch / Edward Barr - LRRI Real-Time NHP and RabbitPlethysmography/Exposure Systems
• Larry E. Bowen - Inhalation Dosimetry in Murine: Bioaerosol Challenge Models
• Kevin Hommema - Development of a New Test Facility for Larger Scale Testing with BSL-3 Agents
• Rigoberto Sanchez - The Use of an Aerosol Delivery System Inside of a Flexible Film Isolator
• Rick Tuttle - Development of an ABSL3 Nose-Only Bioaerosol Exposure System

Session 6

• Richard Beigi - Development of a Non-Traditional Pregnant Animal Model for Aerosol Infection with Influenza
• Richard Warren - AEROSOL INFECTION OF MICE WITH Brucella melitensis 16M
• Divey Saini - Inhalation Animal Models for Emerging Infections and Biodefense
• John A. Lednicky - Different Clinical Outcomes Following Aerosol or Intranasal Exposure to Influenza H5N1 Virus in the Ferret
• Winston Lin - Development of a Bioaerosol Model for Pneumonic Plague in Swiss Webster Mice
• Aysegul Nalca - Comparison of Aerosolized Francisella tularensis in Three Species of Nonhuman Primates

Session 7

• Shannon S. Martin - Evaluation of the Immunogenicity and Efficacy of Inactivated Venezuelan Equine Encephalitis Virus (VEEV) Vaccine Candidates in BALB/c Mice
• Ondraya Espenshade - Evaluation of IMVAMUNE (Modified Vaccinia Virus Ankara-BN ) Vaccine for Time to Protection Against Aerosolized Rabbitpox Virus
• Heather Wargo - Transformational Medical Technologies Initiative (TMTI)

Workshop

• Matthew D. Reed - Defining Aerosol Dose in the Pharmaceutical and Environmental Space: Practical Impacts on Risk Assessment and Treatment Paradigms in Animals and Man
• Chad J. Roy - Experimental Dose in Infectious Disease Studies: Accounting for Depositional Fraction
• Elizabeth Leffel - Dose Calculations: Consider the Differences and Similarities betweenScientific Fields